Results 151 to 160 of about 1,865,175 (347)

On the Role of Entrepreneurial Experience for Start-up Financing: An Empirical Investigation for Germany [PDF]

open access: yes
Entrepreneurs are often faced with problems regarding start-up financing. But compared to novice entrepreneurs, experienced entrepreneurs should have both more knowledge and better contacts, which should potentially reduce the occurrence of problems and ...
Metzger, Georg
core  

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Accessing the density-free regime with ECRH-assisted ohmic start-up on EAST. [PDF]

open access: yesSci Adv
Liu J   +18 more
europepmc   +1 more source

Start-ups as drivers of market mobility: An analysis at the region-sector level for the Netherlands [PDF]

open access: yes
We investigate the impact of start-up rates on a measure of competition among incumbent firms called market mobility. While recent literature suggests that competition among incumbent firms is caused by (lagged) start-up rates, this relation has not yet ...
André van Stel   +2 more
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Accelerating start-up cycles in investigator-initiated multicenter clinical trials. [PDF]

open access: yesJ Clin Transl Sci
Hillery S   +13 more
europepmc   +1 more source

Rapid Start-Up Characteristics of Anammox under Different Inoculation Conditions. [PDF]

open access: yesInt J Environ Res Public Health, 2023
Tan Q, Xia S, Xu W, Jian Y.
europepmc   +1 more source

Home - About - Disclaimer - Privacy